Gender-Specific Independent and Combined Effects of the Progesterone and 17-Hydroxyprogesterone on Metabolic Syndrome: From the Henan Rural Cohort Study
Mian Wang,1,* Luting Nie,1,* Dandan Wei,2 Pengling Liu,2 Li Zhang,2 Keliang Fan,2 Yu Song,1 Lulu Wang,2 Qingqing Xu,2 Juan Wang,2 Xiaotian Liu,2 Linlin Li,2 Zhenxing Mao,2 Chongjian Wang,2 Wenqian Huo1 1Department of Occupational and Environmental Health, College of Public Health, Zh...
Main Authors: | Wang M, Nie L, Wei D, Liu P, Zhang L, Fan K, Song Y, Wang L, Xu Q, Wang J, Liu X, Li L, Mao Z, Wang C, Huo W |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-10-01
|
Series: | Diabetes, Metabolic Syndrome and Obesity |
Subjects: | |
Online Access: | https://www.dovepress.com/gender-specific-independent-and-combined-effects-of-the-progesterone-a-peer-reviewed-fulltext-article-DMSO |
Similar Items
-
A Comparison between the Effects of Vaginal Suppository Progesterone vs. the Injection of 17-Alpha Hydroxyprogesterone Caproate on the Duration of Latent Phase After Controlled Threatened Preterm Labor
by: Fatemeh Mirzaei, et al.
Published: (2018-03-01) -
Patient and Provider Perspectives on Acceptability, Access, and Adherence to 17-Alpha-Hydroxyprogesterone Caproate for Preterm Birth Prevention
by: Stephanie M. Garcia, et al.
Published: (2021-07-01) -
Comparison of Risk of Preterm Labor between Vaginal Progesterone and17-Alpha-Hydroxy-Progesterone Caproate in Women with Threatened Abortion: A Randomized Clinical Trial
by: Abootaleb Beigi, et al.
Published: (2016-07-01) -
Discontinuation of long-established Hydroxyprogesterone Caproate; call for awareness and drug-substitutes: A Letter to the Editor
by: Muhammad Affan, et al.
Published: (2023-10-01) -
Intramuscular 17-hydroxyprogesterone caproate to prevent preterm birth among HIV-infected women in Zambia: study protocol of the IPOP randomized trial
by: Joan T. Price, et al.
Published: (2019-02-01)